Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

NCT00331786 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: nitric oxide-releasing acetylsalicylic acid derivative
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy

Sponsor

Stony Brook University

Collaborators

[object Object]